未登录

D

Daisuke Ibi

Meijo University

H指数:32

被引数:3,432

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Acute systemic immune challenge induces cognitive impairments and anhedonia through interferon-induced transmembrane protein 3 in adult male mice

急性全身性免疫挑战通过干扰素诱导的跨膜蛋白3诱导成年雄性小鼠的认知障碍和快感缺乏

Behavioural Brain Research

IF2.3

2025-09-170

PRE

Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2023-10-2412

OA

Emotional behaviors as well as the hippocampal reelin expression in C57BL/6N male mice chronically treated with corticosterone

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2023-09-011

PRE

Preventive Effect of Betaine Against Cognitive Impairments in Amyloid β Peptide-Injected Mice Through Sirtuin1 in Hippocampus

NEUROCHEMICAL RESEARCH

IF3.8

2022-05-2116

PRE

Preventive Effects of Continuous Betaine Intake on Cognitive Impairment and Aberrant Gene Expression in Hippocampus of 3xTg Mouse Model of Alzheimer's Disease

JOURNAL OF ALZHEIMERS DISEASE

IF3.1

2021-01-1917

PREAI

Reelin Supplementation Into the Hippocampus Rescues Abnormal Behavior in a Mouse Model of Neurodevelopmental Disorders

海马补充Reelin可挽救神经发育障碍小鼠模型的异常行为

FRONTIERS IN CELLULAR NEUROSCIENCE

IF4

2020-09-0226

OAAI

Gut microbiota manipulation during the prepubertal period shapes behavioral abnormalities in a mouse neurodevelopmental disorder model

SCIENTIFIC REPORTS

IF3.9

2020-03-1325

OAAI

Involvement of GAT2/BGT-1 in the preventive effects of betaine on cognitive impairment and brain oxidative stress in amyloid β peptide-injected mice

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2019-01-0127

PREAI

Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3

JOURNAL OF NEUROINFLAMMATION

IF10.1

2018-10-2214

OAAI

Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity

NEUROPSYCHOPHARMACOLOGY

IF7.1

2018-07-0734

OAAI

MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice

MOLECULAR PSYCHIATRY

IF10.1

2017-01-2450

OAAI

Epigenetic signaling in schizophrenia

CELLULAR SIGNALLING

IF3.7

2015-10-0144

OAAI

FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization

NATURE COMMUNICATIONS

IF15.7

2015-05-13124

OAAI

Induction of interferon-induced transmembrane protein 3 gene expression by lipopolysaccharide in astrocytes

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2014-12-0111

PREAI

Matrix metalloproteinase-3 is a possible mediator of neurodevelopmental impairment due to polyI:C-induced innate immune activation of astrocytes

BRAIN BEHAVIOR AND IMMUNITY

IF7.6

2014-05-0116

OAAI

Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules

NEUROBIOLOGY OF DISEASE

IF5.6

2013-05-0131

PREAI

Astroglial IFITM3 mediates neuronal impairments following neonatal immune challenge in mice

IF5.1

2013-02-0458

OA

Effects of sub-acute and sub-chronic inhalation of 1-bromopropane on neurogenesis in adult rats

IF4.6

2013-02-0110

PREAI

Placental Extract Improves Hippocampal Neuronal Loss and Fear Memory Impairment Resulting From Chronic Restraint Stress in Ovariectomized Mice

JOURNAL OF PHARMACOLOGICAL SCIENCES

IF2.9

2012-01-0120

OAAI

Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse

与小鼠Disc1基因外显子2和3的靶向破坏相关的行为改变

HUMAN MOLECULAR GENETICS

IF3.2

2011-09-08119

OAAI